Skyramp | $10,000,000 | (Jun 25, 2025)
OutSee | $2,452,266 | (Jun 25, 2025)
Eventual | $20,000,000 | (Jun 25, 2025)
Certified by Founder
Lodge
IMU Biosciences
start up
United Kingdom
- London
- 25/01/2024
- Series A
- $14,639,787
Mapping the immune system in unprecedented detail and scale. IMU’s discovery platform is building a new understanding of the immune system across health and disease, through next generation high resolution, systems-level immune profiling with AI & ML analytics.
- Industry Biotechnology Research
- Website https://www.imubiosciences.com/
- LinkedIn https://www.linkedin.com/company/imubiosciences/
CubeNexus Inc | $650,000 | (Jun 25, 2025)
Digital Asset | $135,000,000 | (Jun 25, 2025)
Quinn | $11,000,000 | (Jun 25, 2025)
Waltz | $50,000,000 | (Jun 25, 2025)
Jobright.ai | $3,200,000 | (Jun 25, 2025)
Empo Health | $7,000,000 | (Jun 25, 2025)
Blank Metal | $3,000,000 | (Jun 25, 2025)
Chronicle Studios | $11,000,000 | (Jun 25, 2025)
Gemist | $6,000,000 | (Jun 25, 2025)